BI Asset Management Fondsmaeglerselskab’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Buy
7,614
+6,022
+378% +$1.84M 0.02% 362
2026
Q1
$399K Sell
1,592
-3,623
-69% -$901K ﹤0.01% 567
2025
Q4
$1.44M Buy
5,215
+336
+7% +$91.9K 0.01% 465
2025
Q3
$1.28M Buy
4,879
+620
+15% +$151K 0.01% 473
2025
Q2
$932K Buy
4,259
+2,240
+111% +$479K 0.01% 499
2025
Q1
$452K Sell
2,019
-1,013
-33% -$279K 0.01% 580
2024
Q4
$993K Sell
3,032
-1,131
-27% -$356K 0.01% 515
2024
Q3
$1.25M Buy
4,163
+777
+23% +$238K 0.02% 353
2024
Q2
$1.11M Buy
3,386
+77
+2% +$27.2K 0.02% 377
2024
Q1
$1.31M Buy
3,309
+1,348
+69% +$499K 0.02% 316
2023
Q4
$691K Sell
1,961
-241
-11% -$85.3K 0.01% 465
2023
Q3
$826K Buy
2,202
+148
+7% +$57.2K 0.02% 406
2023
Q2
$786K Buy
2,054
+67
+3% +$23.9K 0.02% 398
2023
Q1
$688K Buy
1,987
+651
+49% +$190K 0.02% 400
2022
Q4
$314K Buy
+1,336
New +$317K 0.01% 474
2022
Q3
Sell
-530
Closed -$160K 494
2022
Q2
$160K Buy
+530
New +$172K 0.01% 429
2020
Q4
Sell
-3,972
Closed -$1.09M 497
2020
Q3
$1.09M Buy
3,972
+1,794
+82% +$475K 0.05% 271
2020
Q2
$495K Buy
+2,178
New +$428K 0.03% 348
2020
Q1
Sell
-11,649
Closed -$1.75M 391
2019
Q4
$1.75M Sell
11,649
-7,905
-40% -$1.15M 0.08% 208
2019
Q3
$2.77M Buy
+19,554
New +$2.69M 0.14% 136

Other funds holding WST

BI Asset Management Fondsmaeglerselskab's WST Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its West Pharmaceutical (WST) stake by 378% in Q2 2026, buying an estimated $1.84M and bringing the position to 7,614 shares worth $2.73M. The position accounts for 0.02% of the portfolio, ranked #362.

BI Asset Management Fondsmaeglerselskab first reported a position in WST in Q3 2019 and has held it in 20 quarters since. The position peaked at $2.77M in Q3 2019. 433 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 7,614 shares of West Pharmaceutical worth $2.73M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 6,022 West Pharmaceutical shares in Q2 2026, an estimated $1.84M.
  • West Pharmaceutical made up 0.02% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #362 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in West Pharmaceutical in Q3 2019 and has held it in 20 quarters since.
  • BI Asset Management Fondsmaeglerselskab's West Pharmaceutical position peaked at $2.77M in Q3 2019.
  • 433 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.